Poland· PL-100503089
Avortaxo
A vortioxetine product containing vortioxetinum, registered in Poland by Vipharm S.A.. The same ATC class is registered in 18 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Vortioxetine is registered in 18 of 19 countries.
Countries holding a registration under ATC N06AX26 (vortioxetine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 11 of them publish a price we can compare per daily dose
Vortioxetine · ATC N06AX26
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of vortioxetine costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.73 in France to $1.94 in Switzerland — a ×2.7 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Vortioxetine · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.94
- IT Italy$0.94
- FR France$0.73
The record
At a glance
URPL (Poland)- Active substance
- Vortioxetinum
- Manufacturer
- Vipharm S.A.
- Country
- Poland (PL)
- ATC code
- N06AX26
- ATC class
- Vortioxetine
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 8
- gtin05901812163349
- gtin05901812163356
- gtin05901812163363
- gtin05901812163370
- gtin05901812163387
- gtin05901812163394
- gtin05901812163400
- gtin05901812163417
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
181 interactions on record for vortioxetine.
Graded by severity as the source publishes them — 28 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Vortioxetine · interactions on record
181 records
- 28 severe
- 153 moderate
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Vortioxetine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAVORTAXOVipharm S.A., Ożarów Mazowiecki
- SpainBrintellix 10 mg comprimidos recubiertos con peliculaH. Lundbeck A/S
- FinlandBrintellixH. Lundbeck A/S
- NetherlandsBrintellix 10 mg, filmomhulde tablettenH. Lundbeck A/S
- SwedenBrintellix 10 mg Filmdragerad tablettH. Lundbeck A/S
- IcelandBrintellixH. Lundbeck A/S*
- United StatesTrintellixTakeda Pharmaceuticals America, Inc.
- IrelandBrintellix 10 mg film-coated tabletsH. Lundbeck A/S
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Bremisolan, Jilordi
- Belgium · Vortioxetine Hcs
- Bulgaria · Вареста, Ирсамла
- Cyprus · Etiena, Tirtox
- Czechia · Avortaxo, Banavin
- Germany · Vorilix, Vortioxetin Aristo
- Denmark · Broxeltia, Detrevaqia
- Estonia · Varesta, Vortioxetine Alembic
- Spain · Vortioxetina Alembic, Vortioxetina Aristo
- Finland · Systalkin, Vortioxetine Krka
- France · Vortioxetine Biogaran, Vortioxétine Biogaran
- United Kingdom (Northern Ireland) · Vortioxetine Amarox, Vortioxetine Crescent Pharma
- Greece · Broxeltia, Etiena
- Croatia · Tirtox, Varesta
- Hungary · Avortaxo, Banavin
- Ireland · Vortioxetine Clonmel, Vortioxetine Krka
- Iceland · Brintellix, Vortioxetine Krka
- Italy · Vortioxetina Eg, Vortioxetina Krka
- Lithuania · Irsamla, Varesta
- Latvia · Irsamla, Varesta
- Malta · Devofaroz, Ternizyl
- Netherlands · Qerrassa, Vortioxetine Amarox
- Norway · Brintellix, Seliora
- Portugal · Vortioxetina Anova, Vortioxetina Aristo
- Romania · Irsamla, Varesta
- Sweden · Seliora, Vortioxetin Amarox
- Slovenia · Banavin, Irsamla
- Slovakia · Avortaxo, Banavin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cd5a3507-c812-42bd-b7db-2e63bf2ec965 GET /v1/drugs/cd5a3507-c812-42bd-b7db-2e63bf2ec965?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "10 mg",
"packaging": "05901812163349 ¦ Rp ¦ 163696\n14 tabl. w blistrze\n05901812163356 ¦ Rp ¦ 163697\n28 tabl. w blistrze\n05901812163363 ¦ Rp ¦ 163698\n56 tabl. w blistrze\n05901812163370 ¦ Rp ¦ 163699\n98 tabl. w blistrze\n05901812163387 ¦ Rp ¦ 163700\n14 tabl. w blistrze perforowanym\n05901812163394 ¦ Rp ¦ 163701\n28 tabl. w blistrze perforowanym\n05901812163400 ¦ Rp ¦ 163702\n56 tabl. w blistrze perforowanym\n05901812163417 ¦ Rp ¦ 163703\n98 tabl. w blistrze perforowanym",
"substance": "Vortioxetinum 10 mg",
"common_name": "Vortioxetinum",
"pl_product_id": "100503089",
"pozwolenie_nr": "29500",
"auth_procedure": "DCP",
"authorisation_validity": "2031-01-29"
}See everything about vortioxetine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.